Status:

ACTIVE_NOT_RECRUITING

Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study

Lead Sponsor:

Ohio State University Comprehensive Cancer Center

Conditions:

Acute Lymphoblastic Leukemia

Acute Myeloid Leukemia

Eligibility:

All Genders

60+ years

Phase:

NA

Brief Summary

This clinical trial tests whether a geriatric optimization plan (GO!) works to improve survival in patients over 60 with a hematologic malignancy or bone marrow failure syndrome eligible for allogenei...

Detailed Description

PRIMARY OBJECTIVE: I. To demonstrate that geriatric assessment with management (GAM) intervention will lead to improved physical functioning in allogeneic hematopoietic cell transplant (allo-HCT)-eli...

Eligibility Criteria

Inclusion

  • Age \>= 60 years
  • Diagnosed with hematologic malignancy or bone marrow failure syndrome eligible for allogeneic hematopoietic cell transplantation. This includes acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndrome, myeloproliferative neoplasm, myelofibrosis, chronic myeloid leukemia, chronic lymphocytic leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, and aplastic anemia. Disease specific eligibility for allo-HCT to be determined by treating physician
  • Must be able to understand written and spoken English
  • Must be willing to attend all study visits and comply with study procedures for the entire length of the study

Exclusion

  • Documented history of dementia
  • No possibility of proceeding to allogeneic hematopoietic cell transplant within the next 6 months as determined by treating physician
  • Scheduled admission for allogeneic hematopoietic cell transplant within 30 days of enrollment
  • Inability or unwillingness to give written informed consent

Key Trial Info

Start Date :

June 2 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2025

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT05972577

Start Date

June 2 2021

End Date

December 31 2025

Last Update

January 31 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, United States, 43210